Skip to main content
. 2017 Jan 28;12:31. doi: 10.1186/s13014-016-0736-1

Fig. 1.

Fig. 1

Patient from the recurrence treatment group a: clinical appearence at the start of HT; b: clinical appearence 6 weeks after HT; c: HT treatment plan; d DVH